Blackstone’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Blackstone's JAZZ Position: Q2 2026 in Review
Blackstone opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 4,350 shares worth $1.05M. The stake represents ﹤0.01% of the portfolio and ranks #252 among its holdings.
651 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Blackstone held 4,350 shares of Jazz Pharmaceuticals worth $1.05M as of Q2 2026.
- Jazz Pharmaceuticals was a new Blackstone position in Q2 2026.
- Jazz Pharmaceuticals made up ﹤0.01% of Blackstone's portfolio in Q2 2026, its #252 holding.
- 651 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Blackstone's 13F filing for Q2 2026, filed 14 Aug 2026.